NEWS 

All CLEO centers were invited for an interactive webinar of an hour, ran 2x/day. Staff of nearly all centers were able to attend.

In Oct 2020 all CLEO participants are in the Intervention phase.

Regulatory Milestone: Prolira has EU MDR certification!
We are proud to announce that Prolira is one of the first medical device companies in the world, to be certified according to the new EU MDR. 

Prolira’s EU MDR certifiction is the result of a big team effort headed by Uschi and Rutger. We also wish to thank QAid for its full support and DARE!! Medical Certifications for the effective and constructive auditing and certification process.  
For more information, click on picture above.

After an interruption of 3 months due to the COVID-19 pandemic, the CLEO study most hospital departments were able to restart their work for the CLEO study again.
For more information, click on picture above.

In March 2020 a third lot of hospital departments enrolled in the intervention phase of CLEO (Clinical Evaluation Of DeltaScan)! In this phase they switch completely to using the world’s first objective device (DeltaScan), for detection and monitoring of all their patients at risk of delirium.
In the next months of 2020 all departments will switch the intervention phase.
For more information, click on picture above.

In February 2020 a second lot of hospital departments enrolled in the intervention phase of CLEO (Clinical Evaluation Of DeltaScan)! In this phase they switch completely to using the world’s first objective device (DeltaScan), for detection and monitoring of all their patients at risk of delirium.
In the next months of 2020 all departments will switch the intervention phase.
For more information, click on picture above.